Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Ann Lim

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Human Immunology|March 13, 2017
Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodiesMary Ann Lim, Matthew Palmer, Jennifer Trofe-Clark, et al.
Hepatology (Baltimore, Md.)|February 18, 2017
Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infectionJonathan J Hogan, Mary Ann Lim, Matthew B Palmer, et al.
Transplantation|September 9, 2017
Patient and Kidney Allograft Survival in Recipients With End-Stage Renal Disease From AmyloidosisDeirdre Sawinski, Mary Ann Lim, Jordana B Cohen, et al.
Transplantation Direct|May 11, 2026
Practical Guide to Address Common Myths in the Pre- and Post-kidney Transplant Management of the Elderly Patient with Cancer: An Opinion PaperMary Ann Lim, Naoka Murakami, Christopher D Blosser, et al.
Clinical Transplantation|March 20, 2019
Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantationStephanie Hamel, Vicky Kuo, Deirdre Sawinski, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant RecipientsJennifer Trofe-Clark, Daniel C Brennan, Patricia West-Thielke, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 27, 2010
Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infectionPeter P Reese, Tara Tehrani, Mary Ann Lim, et al.
Transplantation Direct|October 3, 2019
Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant RecipientsAlexander H Morrison, Meera Gupta, Kelsey Lloyd, et al.
Clinical Transplantation|October 7, 2025
Long-Term Outcomes of BK Viremia in Kidney Transplant RecipientsSrijan Tandukar, Qufei Wu, Sneha Chandrashekar, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 6, 2019
Bariatric surgery before and after kidney transplantation: long-term weight loss and allograft outcomesJordana B Cohen, Mary Ann Lim, Colleen M Tewksbury, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Human Immunology|March 13, 2017
Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodiesMary Ann Lim, Matthew Palmer, Jennifer Trofe-Clark, et al.
Hepatology (Baltimore, Md.)|February 18, 2017
Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infectionJonathan J Hogan, Mary Ann Lim, Matthew B Palmer, et al.
Transplantation|September 9, 2017
Patient and Kidney Allograft Survival in Recipients With End-Stage Renal Disease From AmyloidosisDeirdre Sawinski, Mary Ann Lim, Jordana B Cohen, et al.
Transplantation Direct|May 11, 2026
Practical Guide to Address Common Myths in the Pre- and Post-kidney Transplant Management of the Elderly Patient with Cancer: An Opinion PaperMary Ann Lim, Naoka Murakami, Christopher D Blosser, et al.
Clinical Transplantation|March 20, 2019
Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantationStephanie Hamel, Vicky Kuo, Deirdre Sawinski, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant RecipientsJennifer Trofe-Clark, Daniel C Brennan, Patricia West-Thielke, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 27, 2010
Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infectionPeter P Reese, Tara Tehrani, Mary Ann Lim, et al.
Transplantation Direct|October 3, 2019
Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant RecipientsAlexander H Morrison, Meera Gupta, Kelsey Lloyd, et al.
Clinical Transplantation|October 7, 2025
Long-Term Outcomes of BK Viremia in Kidney Transplant RecipientsSrijan Tandukar, Qufei Wu, Sneha Chandrashekar, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 6, 2019
Bariatric surgery before and after kidney transplantation: long-term weight loss and allograft outcomesJordana B Cohen, Mary Ann Lim, Colleen M Tewksbury, et al.
Pageof 3